BiotechTube

Fluconazole

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fungal Infection by Site

Conditions

Fungal Infection by Site

Trial Timeline

Jul 1, 2008 → Dec 1, 2009

NCT ID
NCT00721487

About Fluconazole

Fluconazole is a pre-clinical stage product being developed by Astellas Pharma for Fungal Infection by Site. The current trial status is completed. This product is registered under clinical trial identifier NCT00721487. Target conditions include Fungal Infection by Site.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT00721487Pre-clinicalCompleted

Competing Products

20 competing products in Fungal Infection by Site

See all competitors
ProductCompanyStageHype Score
BSG005Alkem LaboratoriesPhase 1/2
41
MicafunginAstellas PharmaPhase 1
33
MicafunginAstellas PharmaPre-clinical
23
amphotericin B liposomal (Ambisome)Astellas PharmaApproved
85
Parenteral micafungin application + Other parenteral antifungal drugsAstellas PharmaPre-clinical
23
Isavuconazonium sulfate + Voriconazole + PosaconazoleAstellas PharmaPre-clinical
23
MicafunginAstellas PharmaPre-clinical
23
MicafunginAstellas PharmaPre-clinical
23
MicafunginAstellas PharmaPhase 1
33
Micafungin + PlaceboAstellas PharmaPhase 3
77
Posaconazole + Voriconazole + PlaceboMerckPhase 3
77
caspofungin acetate + Comparator: Micafungin sodiumMerckPhase 3
77
caspofungin acetateMerckPhase 3
77
PosaconazoleMerckPhase 1
33
PosaconazoleMerckApproved
85
Posaconazole IV 6 mg/kg + Posaconazole PFS 6 mg/kgMerckPhase 2
52
Posaconazole oral suspension 40 mg/mLMerckPre-clinical
23
Posaconazole 12 mg/kg/day BID + Posaconazole 18 mg/kg/day BID + Posaconazole 18 mg/kg/day TID + Posaconazole 12 mg/kg/day TIDMerckPhase 1
33
caspofungin acetateMerckPhase 2
52
PosaconazoleMerckPhase 1
33

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85